Showing 3,401 - 3,420 results of 5,343 for search 'registration (developments OR development)', query time: 0.18s Refine Results
  1. 3401

    A Mindfulness-Based Lifestyle Intervention for Dementia Risk Reduction: Protocol for the My Healthy Brain Feasibility Randomized Controlled Trial by Ryan A Mace, Makenna E Law, Joshua E Cohen, Christine S Ritchie, Olivia I Okereke, Bettina B Hoeppner, Judson A Brewer, Stephen J Bartels, Ana-Maria Vranceanu

    Published 2024-11-01
    “…We are iteratively developing and testing My Healthy Brain (MHB), the first mindfulness-based lifestyle group program targeting AD/ADRD risk factors in older adults with subjective cognitive decline. …”
    Get full text
    Article
  2. 3402

    Effectiveness of clinical healthcare interventions for enhancing the work participation of patients with various health conditions: a synthesis of systematic reviews by Jan L Hoving, Astrid de Wind, Angela G E M de Boer, Annechien Beumer, Faridi S Jamaludin, Lana Kluit, Coen A M van Bennekom

    Published 2025-02-01
    “…More evidence is needed on developing tailored interventions and evaluating their cost-effectiveness.PROSPERO registration number CRD42022346552.…”
    Get full text
    Article
  3. 3403
  4. 3404
  5. 3405

    Nurse-Delivered Telehealth in Home-Based Palliative Care: Integrative Systematic Review by Cong Ma, Yifan Fang, Hui Zhang, Ying Zheng, Ying Zhang, Wanchen Zhao, Ge Yan, Yaoxin Zeng, Yanwu Zhang, Xiaohong Ning, Zhimeng Jia, Na Guo

    Published 2025-05-01
    “…With the empowerment of telehealth technologies, nurses could establish a stronger professional identity and develop leadership in home-based palliative care. …”
    Get full text
    Article
  6. 3406

    Determination of the stability of a nonsteroidal anti-inflammatory drug for dogs based on celecoxib by R. M. Sachuk, V. M. Hunchak, M. L. Kondratyuk, T. A. Velesyk

    Published 2025-04-01
    “…Further studies will be the next stage of pre-registration testing aimed at developing the section “Data reflecting the risk assessment for the environment”, which is a mandatory material of the part “Chemical, pharmaceutical and biological documentation” of the dossier for this veterinary drug. …”
    Get full text
    Article
  7. 3407

    Prolonged dual hypothermic oxygenated machine preservation (DHOPE-PRO) in liver transplantation: study protocol for a stage 2, prospective, dual-arm, safety and feasibility clinica... by Aad P van den Berg, Hans Blokzijl, Marieke T de Boer, Frans van der Heide, Ruben H J de Kleine, Otto B van Leeuwen, Ton Lisman, Vincent E de Meijer, Anne Loes Van den Boom, Joost M Klaase, Peter Meyer, Robert J Porte, Frederike G I van Vilsteren, Frans J C Cuperus, Martijn P D Haring, Isabel M A Brüggenwirth, Veerle A Lantinga, Michel Rayar, Koen M E M Reyntjens, Carlijn I Buis, Suomi MG Fouraschen, Frederik JH Hoogwater, Mark Meerdink, Maarten W Nijkamp, A Michel Rayar, Ilhama F Abbasova, Meine H Fernhout, Ernesto R R Muskiet, Jaap J Vos, Miriam Zeillemaker, Bianca Lascaris, Carol C Pamplona, Adam M Thorne, Silke B Bodewes

    Published 2022-11-01
    “…In addition to graft reconditioning, DHOPE may also be used to prolong preservation time, which could facilitate logistics for allocation and transplantation globally.Methods and analysis This is a prospective, pseudo-randomised, dual-arm, IDEAL-D (Idea, Development, Exploration, Assessment, Long term study-Framework for Devices) stage 2 clinical device trial designed to determine safety and feasibility of prolonged DHOPE (DHOPE-PRO). …”
    Get full text
    Article
  8. 3408
  9. 3409
  10. 3410

    The first generic tirzepatide GP30931: physicochemical and biological similarity to the reference drug by I. A. Lugovik, A. V. Babina, S. S. Arutyunyan, D. О. Ermolaeva, V. B. Saparova, T. N. Kobeleva, P. G. Zaikin, A. D. Mikushina, A. S. Bukatin, I. E. Eliseev, B. Ts. Zajchik, Y. S. Keruchenko, I. S. Ohrimenko, E. V. Bocharov, A. Kh. Taldaev, V. A. Lushpa, I. E. Makarenko, R. V. Drai

    Published 2025-06-01
    “…The original drug (Mundjaro, pln: tirzepatide) is not registered in the Eurasian Economic Union (EAEU), which limits its availability to patients and leads to the need to develop a domestic generic.Aim. Conducting a physicochemical and biological characterization of the drug Sejaro® (GP30931) in comparison with the original drug Mundjaro® to establish their comparability.Materials and methods. …”
    Get full text
    Article
  11. 3411

    Improving regional care in the last year of life by setting up a pragmatic evidence-based Plan–Do–Study–Act cycle: results from a cross-sectional survey by Lena Ansmann, Holger Pfaff, Ingrid Schubert, Ludwig Kuntz, Stephanie Stock, Sheila Payne, Nadine Scholten, Ute Karbach, Stefanie Hamacher, Raymond Voltz, Christian Albus, Frank Jessen, Christian Rietz, Frank Schulz-Nieswandt, Julia Strupp, Gloria Dust, Nicolas Schippel

    Published 2020-11-01
    “…Objectives To set up a pragmatic Plan–Do–Study–Act cycle by analysing patient experiences and determinants of satisfaction with care in the last year of life.Design Cross-sectional postbereavement survey.Setting Regional health services research and development structure representing all health and social care providers involved in the last year of life in Cologne, a city with 1 million inhabitants in Germany.Participants 351 bereaved relatives of adult decedents, representative for age and gender, accidental and suspicious deaths excluded.Results For the majority (89%) of patients, home was the main place of care during their last year of life. …”
    Get full text
    Article
  12. 3412

    Peer-Assisted Lifestyle (PAL) intervention: a protocol of a cluster-randomised controlled trial of a health-coaching intervention delivered by veteran peers to improve obesity trea... by Stephanie L Orstad, Melanie Jay, Victoria Sweat, Sandra Wittleder, Scott E Sherman, Jeannette M Beasley, Shea Smith, Binhuan Wang, Allison Squires, Laura Wong, Yixin Fang, Paula Doebrich, Damara Gutnick, Craig Tenner

    Published 2021-02-01
    “…Repeated measures modelling based on mixed models will compare mean BM loss (primary outcome) between study arms.Ethics and dissemination The protocol has been approved by the Institutional Review Board and the Research and Development Committee at the VA NY Harbor Health Systems (#01607). …”
    Get full text
    Article
  13. 3413

    PANDA study: subtyping of Parkinson’s disease – cohort study protocol by Yan Li, Rui Yang, Zihao Li, Mengfei Cai, Chentao He, Siming Rong, Ziqi Gao, Qibing Luo, Xilie Cui, Piao Zhang, Yuhu Zhang

    Published 2025-07-01
    “…The classification of PD into distinct subtypes remains a major challenge, limiting the development of precision medicine approaches. Existing subtyping methods have relied on clinical features, genetic markers or isolated biomarkers, but an integrated classification system incorporating neuroimaging and fluid biomarkers is lacking. …”
    Get full text
    Article
  14. 3414
  15. 3415
  16. 3416
  17. 3417

    Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised... by Nigel Garrett, Sharana Mahomed, Edmund Capparelli, Cheryl Baxter, Nonhlanhla Yende Zuma, Tanuja Gengiah, Derseree Archary, Penny Moore, Natasha Samsunder, Dan H Barouch, John Mascola, Julie Ledgerwood, Lynn Morris, Salim Abdool Karim

    Published 2019-07-01
    “…Introduction Despite extensive prevention campaigns and scale-up of antiretroviral therapy, HIV incidence among young women in southern Africa remains high. While the development of an efficacious vaccine remains a challenge, the discovery of broadly neutralising monoclonal antibodies (mAbs) has created the opportunity to explore passive immunisation as a long-acting injectable HIV prevention strategy. …”
    Get full text
    Article
  18. 3418

    Rheumatoid Arthritis Real-world Cohort Study in China (ReALSA): protocol for a multicentre prospective, longitudinal cohort study by Long Zhang, Ying Yang, Lie Dai, Yingying Zhu, Jian-Zi Lin, Ze-Hong Yang, Qian-Hua Li, Zhi-Ming Ouyang, Hai-Jun Liu, Yao-Wei Zou, Kui-Min Yang, Li-Juan Yang, Ying-Qian Mo, Jian-Da Ma

    Published 2025-07-01
    “…Dissemination of results will occur via national and international conferences, in peer-reviewed journals, public conferences and social media.Trial registration number NCT06233929.…”
    Get full text
    Article
  19. 3419

    Sex as a prognostic factor for mortality in critically ill adults with sepsis: a systematic review and meta-analysis by Alba Antequera, Alfonso Muriel, Rosa del Campo, Javier Zamora, Elena Stallings, Gerard Urrútia, Ivan Solà, Jesus Lopez-Alcalde, Manuel Ponce-Alonso, Federico Gordo, Pilar Fidalgo, Ana Verónica Halperin, Noelia Álvarez-Díaz, Olaya Madrid-Pascual, Borja Fernández Félix

    Published 2021-09-01
    “…The Grades of Recommendations, Assessment, Development and Evaluation approach was used to rate the certainty of evidence.Results From 14 304 records, 13 studies (80 520 participants) were included. …”
    Get full text
    Article
  20. 3420

    Incidence and risk factors of acute kidney injury after abdominal surgery: a systematic review and meta-analysis by Jian Liu, Shi-hui Lin, Yi-si Zhao, Ren-jie Luo, Zheng-tao Zhang, Liu-yang Wang, Ke Xie, Jing Fan, Mu Zhang, Yu-sen Chai, Hong Tang, Fang Xu

    Published 2025-12-01
    “…Objective To determine the incidence of acute kidney injury (AKI) following abdominal surgery, assess its outcome associations, and identify factors associated with postoperative AKI development.Methods We performed a systematic search of PubMed, Embase, and Cochrane Database of Systematic Reviews, from January 2004, to December 2024. …”
    Get full text
    Article